Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis. [PDF]
Loap P +5 more
europepmc +1 more source
Whole-Brain Radiotherapy Simultaneous Integrated Boost Intensity-Modulated Radiotherapy Combined With Anlotinib in the Treatment of Brain Metastases. [PDF]
Tao W +9 more
europepmc +1 more source
Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. [PDF]
Tang L, Li X, Wang Y, Tong Y.
europepmc +1 more source
Efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative chemotherapy treatment of multifocal high-grade glioma. [PDF]
Jiang N, Xu LP, Li F, Wang PP, Cao Y.
europepmc +1 more source
The dosimetric value and safety evaluation of 3D printed bolus in adjuvant intensity-modulated radiotherapy after radical mastectomy for breast cancer: a prospective cohort study. [PDF]
Wang Y, Li H, Hu W, Li B, Du Y, Li F.
europepmc +1 more source
Concurrent nimotuzumab and intensity-modulated radiotherapy for elderly patients with locally advanced nasopharyngeal carcinoma. [PDF]
Cao C +11 more
europepmc +1 more source
Related searches:
Intensity modulated radiotherapy
2012Intensity-modulated radiotherapy (IMRT) is a radiation delivery technique that allows “dose sculpting” to improve target coverage while sparing normal tissues. In an IMRT plan, the number of photons delivered (or “fluence”) varies within a field. Such variability can be used to avoid normal structures with lower radiation tolerance than the cancer and ...
Bridget F. Koontz +2 more
openaire +2 more sources
Conformal Radiotherapy and Intensity-modulated Radiotherapy: Clinical Data
Acta Oncologica, 2000Conformal radiotherapy (CRT) is based on three hypotheses: (i) a higher rate of local control can improve the survival rate; (ii) dose escalation can increase tumor control; and (iii) CRT allows the delivery of higher doses by decreasing the incidence of late effects. These postulates are now supported by several data.
M, Tubiana, F, Eschwège
openaire +2 more sources
Submandibular Gland-sparing Intensity-modulated Radiotherapy
American Journal of Clinical Oncology, 2014Xerostomia is one of the most debilitating late effects of head and neck radiotherapy (RT) and significantly impacts quality of life. The submandibular gland (SMG) provides approximately 70% of the unstimulated saliva that accounts for about 95% of the salivary flow during a 24-hour period. Intensity-modulated RT (IMRT) has been used in recent years to
William M, Mendenhall +2 more
openaire +2 more sources

